Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10925976 | Smooth muscle specific inhibition for anti-restenotic therapy | Hana Totary-Jain, Steven Marx | 2021-02-23 |
| 8710045 | Agents for preventing and treating disorders involving modulation of the ryanodine receptors | Donald W. Landry, Shixian Deng | 2014-04-29 |
| 8022058 | Agents for preventing and treating disorders involving modulation of the RyR receptors | Donald W. Landry, Shixian Deng | 2011-09-20 |
| 7879840 | Agents for preventing and treating disorders involving modulation of the RyR receptors | Donald W. Landry, Shixian Deng | 2011-02-01 |
| 7718644 | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof | Donald W. Landry, Shixian Deng, Zhen Cheng | 2010-05-18 |
| 7662178 | C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis | Steven Marx | 2010-02-16 |
| 7544678 | Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) | Donald W. Landry, Shixian Deng, Zhen Cheng | 2009-06-09 |
| 7393652 | Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2) | — | 2008-07-01 |
| 7364586 | C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis | Steven Marx | 2008-04-29 |
| 7312044 | Type 1 ryanodine receptor-based methods | — | 2007-12-25 |
| 6489125 | Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor | Steven Marx | 2002-12-03 |